Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (2253)	1/23/2001 4:54:38 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 4974

``Millennium ended 2000 in its strongest business position ever,'' said Kevin Starr, chief financial officer of Millennium. ``We believe that our substantial cash position of $1.5 billion and a committed revenue source from partners; combined with the strength of our technology platform and a deep early-stage pipeline, with ownership of small molecules, antibodies and predictive medicine programs in our key franchise areas; put us in a unique position to build a company that will truly revolutionize medicine.''